Table 2.
Characteristics of included studies.
| Authors and year of publication | Country | Study design | Time period of study | Sample size | Female (%) | Age [median, IQR, mean (SD)] | Number of deaths | Mortality rate (%) | CVD (%) | HTN (%) | DM (%) | CLD (%) | CKD (%) | HIV (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Abayomi et al 2020[19] | Nigeria | Retrospective cohort study | Submit on September 2, 2020 | 2184 | 34.2 | 43 ± 16 | 87 | 4 | – | 16.7 | 6.8 | – | 0.6 | 0.3 |
| 2. AbdelG haffar et al 2022[20] | Egypt | Retrospective cohort study | April–July 2020 | 3712 | 51.1 | – | 900 | 24.2 | 8.1 | 29.7 | 31.1 | – | 4.1 | – |
| 3. Abebe et al 2022[21] | Ethiopia | Retrospective cohort study | May7–October 28, 2020 | 925 | 30 | 30(25–44) | 56 | 6.1 | 42.2 | – | 25.0 | 16.4 | 4.3 | 5.2 |
| 4. Allwood et al 2022[22] | South Africa | Prospective study | November 5, 2020–30 April 2021 | 82 | 67 | 46 | 54 | 65.8 | – | 48 | 41 | 2 | – | 11 |
| 5. Apiyo et al 2022[23] | Uganda | Retrospective cohort study | June 2020–September 2021 | 160 | 36.5 | 45 (37–57) | 18 | 11.3 | – | 26.9 | 16.9 | – | – | 1.9 |
| 6. Baguma et al 2022[24] | Uganda | Retrospective cohort study | March 2020–October 2021 | 664 | – | – | 32 | 4.8 | – | – | – | – | – | – |
| 7. Bepouka et al 2020[25] | DRC | Retrospective cohort study | March 23–June 15, 2020 | 141 | 32.6 | 49.6 ± 16.5 | 41 | 29.1 | 4.3 | 23.4 | 17.0 | 2.8 | – | – |
| 8. Bepouka et al 2022[26] | DRC | Retrospective cohort study | March 2020–May 2021 | 222 | 28.45 | 70(64–74) | 97 | 43.7 | 3.45 | 52.51 | 27.49 | – | – | – |
| 9. Boateng et al 2020[27] | Ghana | Prospective study | June 1–July 27 2020 | 25 | 44 | 59.3 ± 20.6 | 4 | 16 | 24 | 72 | 36 | – | – | – |
| 10. Donamou et al 2021[28] | Guinea | Retrospective cohort study | March 12–July 12, 2020 | 140 | 21 | 58 ± 14 | 35 | 25 | – | – | – | – | – | – |
| 11. Jaspard et al 2021[29] | Burkina Faso and Guinea | Prospective cohort study | March 1–November 12, 2020 (Burkina) April 1–November 4 (Guinea) | 1805 | 36.0 | 41(30–57) | 90 | 5 | – | 21 | 12 | – | – | – |
| 12. Kaso et al 2022[30] | Ethiopia | Retrospective cohort study | July 1, 2020–March 5, 2021 | 422 | 38.6 | 41.06 ± 20.61 | 47 | 11.14 | 6.9 | 9.5 | 17.1 | 11.4 | 2.1 | 2.8 |
| 13. Katoto et al 2021[31] | Niger | Retrospective cohort study | March 19–November 17, 2020 | 729 | 28.12 | 40(30–61) | 85 | 11.66 | 83.48 | – | 75.32 | 58.70 | 20.83 | 13.64 |
| 14. Matangila et al 2020[32] | DRC | Retrospective cohort study | March 11–July 22, 2020 | 160 | 49 | 54(38–64) | 32 | 20 | 7 | 34 | 19 | 3 | – | – |
| 15. Nachega et al 2020[33] | DRC | Retrospective cohort study | March 10–July 31, 2020 | 766 | 34.4 | 46(34–58) | 101 | 13.2 | 3.9 | 25.4 | 14.0 | 3.4 | 0.9 | 1.6 |
| 16. Nassar et al 2021[34] | Egypt | Retrospective cohort study | April 28–July 29, 2020 | 160 | 32.5 | 60 ± 14 | 39 | 24.4 | 20.6 | 55.6 | 45.6 | 10.6 | 9.4 | – |
| Total | NA | NA | NA | 12297 | NA | NA | 1718 | NA | NA | NA | NA | NA | NA | NA |
CKD = chronic kidney disease, CLD = chronic lung diseases, CVD = cardiovascular diseases, DM = diabetes mellitus, DRC = the Democratic Republic of the Congo, HIV = human immunodeficiency virus, HTN = hypertension, IQR = interquartile range, NA = not applicable, SD = standard deviation.